LYTIR

Company · KURA

Kura Oncology, Inc.

Nasdaq's symbol directory lists KURA on Nasdaq as “Kura Oncology, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($2.4M); insiders sold on 12 occasions ($2.5M); 10 planned-sale notices; 2 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $2.4M in total; Insider sales: $2.5M in total.Jun: Insider sales $834KAug: Insider purchases $2.4MAug: Insider sales $449KSep: Insider sales $1.3MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $2.4MInsider sales below: $2.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Troy E. Wilson, President and CEO bought on 2 days latest Aug 24, 2026 bought $2.4M
  2. Mollie Leoni, Chief Medical Officer sold on 3 days 2 of them under a 10b5-1 plan latest Sep 29, 2026 sold $1.3M
  3. Bair Teresa Brophy, Chief Legal Officer sold on 2 days all under a 10b5-1 plan latest Sep 28, 2026 sold $486K
  4. Powl Brian T., Chief Commercial Officer sold on 3 days all under a 10b5-1 plan latest Sep 29, 2026 sold $397K
  5. Burrows Francis, Chief Scientific Officer sold on 1 day latest Sep 24, 2026 sold $225K
  6. FORD KATHLEEN, Chief Operating Officer sold on 2 days all under a 10b5-1 plan latest Sep 29, 2026 sold $112K
  7. DOYLE THOMAS JAMES, SVP, Finance & Accounting sold on 1 day latest Sep 28, 2026 sold $48K
Every trade (14)
  1. SELLMollie Leoni, Chief Medical Officer sold Sep 29, 2026 28,802 shares 10b5-1 plan (scheduled) filing $310K
  2. SELLPowl Brian T., Chief Commercial Officer sold Sep 29, 2026 15,430 shares 10b5-1 plan (scheduled) filing $166K
  3. SELLFORD KATHLEEN, Chief Operating Officer sold Sep 29, 2026 3,668 shares 10b5-1 plan (scheduled) filing $39K
  4. SELLPowl Brian T., Chief Commercial Officer sold Sep 28, 2026 17,020 shares 2 legs combined 10b5-1 plan (scheduled) filing $179K
  5. SELLMollie Leoni, Chief Medical Officer sold Sep 28, 2026 12,448 shares filing $131K
  6. SELLBair Teresa Brophy, Chief Legal Officer sold Sep 28, 2026 8,442 shares 10b5-1 plan (scheduled) filing $89K
  7. SELLFORD KATHLEEN, Chief Operating Officer sold Sep 28, 2026 6,906 shares 10b5-1 plan (scheduled) filing $72K
  8. SELLDOYLE THOMAS JAMES, SVP, Finance & Accounting sold Sep 28, 2026 4,607 shares filing $48K
  9. SELLBurrows Francis, Chief Scientific Officer sold Sep 24, 2026 20,726 shares filing $225K
  10. BUYTroy E. Wilson, President and CEO bought Aug 24, 2026 100,000 shares filing $1.2M
  11. SELLPowl Brian T., Chief Commercial Officer sold Aug 21, 2026 4,345 shares 10b5-1 plan (scheduled) filing $52K
  12. SELLBair Teresa Brophy, Chief Legal Officer sold Aug 19, 2026 31,487 shares 10b5-1 plan (scheduled) filing $398K
  13. BUYTroy E. Wilson, President and CEO bought Aug 17, 2026 100,000 shares filing $1.1M
  14. SELLMollie Leoni, Chief Medical Officer sold Jun 18, 2026 84,929 shares 10b5-1 plan (scheduled) filing $834K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. MOLLIE LEONI filed Sep 29, 2026 Officer 28,802 shares planned sale date 09/29/2026 filing $306K
  2. BRIAN POWL filed Sep 29, 2026 Officer 15,430 shares planned sale date 09/29/2026 filing $164K
  3. KATHLEEN FORD filed Sep 29, 2026 Officer 3,668 shares planned sale date 09/29/2026 filing $39K
  4. LEONI MOLLIE filed Sep 28, 2026 Officer 12,448 shares planned sale date 09/28/2026 filing $134K
  5. POWL BRIAN T filed Sep 28, 2026 Officer 9,020 shares planned sale date 09/28/2026 filing $97K
  6. BAIR TERESA BROPHY filed Sep 28, 2026 Officer 8,442 shares planned sale date 09/28/2026 filing $91K
  7. BRIAN POWL filed Sep 28, 2026 Officer 8,000 shares planned sale date 09/28/2026 filing $86K
  8. FORD KATHLEEN filed Sep 28, 2026 Officer 6,906 shares planned sale date 09/28/2026 filing $74K
  9. DOYLE THOMAS JAMES filed Sep 28, 2026 Officer 4,607 shares planned sale date 09/28/2026 filing $50K
  10. FRANCIS J BURROWS filed Sep 24, 2026 Officer 20,726 shares planned sale date 09/24/2026 filing $225K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G/A passive 7,908,832 shares filing 8.9%
  2. Montanova Capital, LLC filed Aug 14, 2026 Schedule 13G/A passive filing 9.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Sep 9, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.